Ernexa Therapeutics (ERNA) Non-Current Assets (2009 - 2026)
Ernexa Therapeutics (ERNA) posted Non-Current Assets of $421,000 for Q2 2026, down 84.9% from $2.79 million a year earlier and down 23.0% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics' Non-Current Assets came in at $2.7 million, down 7.4% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of -24.7% (FY2020 to FY2025).
- In prior years, Ernexa Therapeutics' Non-Current Assets was $2.92 million in FY2024 (-92.6%), $39.53 million in FY2023 (+359.8%), $8.6 million in FY2022 (-32.6%) and $12.76 million in FY2021 (+14.2%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Assets has declined in each of the last nine quarters, with an average decline of 69.1% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2023, with growth of 791.2%; the weakest was Q2 2025, with a decline of 93.5%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $547,000 (Q1 2026), $2.7 million (Q4 2025) and $2.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | 376,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 376,000.00 |
| Jun 30, 2026 | 421,000.00 |
| Mar 31, 2026 | 547,000.00 |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 42.90 Mn |
| Mar 31, 2024 | 43.49 Mn |
| Dec 31, 2023 | 39.53 Mn |
| Sep 30, 2023 | 45.22 Mn |
| Jun 30, 2023 | 43.06 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | 8.60 Mn |
| Sep 30, 2022 | 5.07 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 10.24 Mn |
| Dec 31, 2021 | 12.76 Mn |
API Access
Ernexa Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();